Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7255 results

Sort By:

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

Study ID: NCT03659448
Start Date: 2019-06-17
End Date: 2024-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

SGM-101

Sponsor

Surgimab

Source: clinicaltrials.gov

Share:
Add to list

Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery

Study ID: NCT05029726
Start Date: 2022-02-01
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

125

Intervention / Treatment

Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine

normal saline

Sponsor

John O'Toole

Source: clinicaltrials.gov

Share:
Add to list

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Study ID: NCT06227026
Start Date: 2024-02-20
End Date: 2027-01-15
Study Type

Interventional

Study Phase

Phase1

No. of Participants

6

Intervention / Treatment

Anti-CD19 CAR-T cells

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

Investigations of Reproductive Cancers in Women

Study ID: NCT06527157
Start Date: 2024-07-30
End Date: 2026-11-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

4500

Intervention / Treatment
Sponsor

PinkDx, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Study ID: NCT06238648
Start Date: 2024-01-31
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Biopsy

Biospecimen Collection

Computed Tomography

Epcoritamab

Magnetic Resonance Imaging

Patient Observation

Positron Emission Tomography

Sponsor

Academic and Community Cancer Research United

Source: clinicaltrials.gov

Share:
Add to list

Brain Slice Explants to Predict Drug Response in Brain Tumors

Study ID: NCT05978557
Start Date: 2023-07-27
End Date: 2028-03-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Biospecimen collection

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT

Study ID: NCT05442957
Start Date: 2023-02-14
End Date: 2027-03-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

BRIGHT

Attention Control

Sponsor

Medical University of South Carolina

Source: clinicaltrials.gov

Share:
Add to list

Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk

Study ID: NCT06557057
Start Date: 2023-11-16
End Date: 2025-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

75

Intervention / Treatment

Non-Interventional Study

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Study ID: NCT05879926
Start Date: 2023-08-31
End Date: 2034-07
Study Type

Interventional

Study Phase

Phase3

No. of Participants

3960

Intervention / Treatment

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Sponsor

NRG Oncology

Source: clinicaltrials.gov

Share:
Add to list

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Study ID: NCT06228326
Start Date: 2024-04-17
End Date: 2028-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

Chest 07

Pembrolizumab (KEYTRUDA®)

Chemotherapy

Sponsor

Krystal Biotech, Inc.

Source: clinicaltrials.gov

Share:
Add to list